Estrogens, regulation of p53 and breast cancer risk: a balancing act

被引:0
作者
D. Joseph Jerry
Karen A. Dunphy
Mary J. Hagen
机构
[1] University of Massachusetts,Paige Laboratory, Department of Veterinary and Animal Sciences
[2] Pioneer Valley Life Sciences Institute,undefined
来源
Cellular and Molecular Life Sciences | 2010年 / 67卷
关键词
P53; Breast cancer; Estrogen receptor alpha; Estrogen receptor beta; Parity; Risk; Epigenetics;
D O I
暂无
中图分类号
学科分类号
摘要
The paradoxical effects of ovarian hormones in both the promotion and prevention of breast cancer have been debated for over 30 years. Genetic studies have demonstrated that ovarian hormones act through NF-κB to stimulate proliferation and ductal elongation, whereas the p53 tumor suppressor protein plays a central role in rendering the mammary epithelium resistant to tumorigenesis. Transcriptional profiles now suggest that ovarian hormones stimulate a constellation of genes that interact with NF-κB and p53 to arbitrate the competing demands for proliferation and surveillance. Genes that participate in chromatin remodeling are among the acute transcriptional responses to estrogens and progestins. These genes are proposed to initiate epigenetic programs that influence the balance between proliferation and surveillance, and render the breast epithelium resistant to tumors.
引用
收藏
页码:1017 / 1023
页数:6
相关论文
共 525 条
[11]  
Guttenplan J(1985)Chemoprevention of J Natl Cancer Inst 74 927-1581
[12]  
Hart E(1998)-nitroso- Carcinogenesis 19 1573-748
[13]  
Ingle J(2004)-methylurea-induced mammary cancers by pretreatment with 17 beta-estradiol and progesterone Carcinogenesis 25 741-4628
[14]  
Jankowiak R(2001)Hormone-induced refractoriness to mammary carcinogenesis in Wistar–Furth rats Oncogene 20 4621-87
[15]  
Muti P(2001)Prepubertal estradiol and genistein exposures up-regulate BRCA1 mRNA and reduce mammary tumorigenesis Cancer Epidemiol Biomarkers Prev 10 83-629
[16]  
Rogan E(2007)Relative frequency and morphology of cancers in carriers of germline TP53 mutations Hum Mutat 28 622-1689
[17]  
Russo J(1998)Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers Oncogene 17 1681-43
[18]  
Santen R(1999)Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database Nat Genet 22 37-59
[19]  
Sutter T(2002)p53 mutation with frequent novel condons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours Nat Genet 31 55-602
[20]  
Frech MS(2004)Conditional mutation of Cell 119 591-1058